5/21/2020 | HY | New Issue: PPD prices upsized $1.2 billion senior notes in revised two-part deal
|
5/21/2020 | HY | PPD talks $700 million eight-year senior notes to yield 5%-5¼%; pricing Thursday
|
8/5/2015 | HY | Market Commentary: Upsized First Data drive-by leads biggest primary day since June; new Party City jumps
|
8/5/2015 | BKCVDDEMIGPV | Market Commentary: Upsized First Data drive-by leads biggest primary day since June; new Party City jumps
|
1/22/2013 | BK | Pharmaceutical Product Development to hold lender call on Wednesday
|
10/15/2012 | HY | Market Commentary: Nortek, Nuance bring add-ons; Vantage megadeal on tap; Sprint jumps on sale to Softbank
|
10/11/2012 | HY | Market Commentary: Momentive mega-deal, Cequel, BI-LO price; Sprint up on Softbank news; funds lose $114 million
|
10/10/2012 | HY | New Issue: PPDI prices upsized $525 million five-year PIK toggle notes
|
10/10/2012 | HY | Market Commentary: TransDigm, CVR, Shelf Drilling lead $2 billion primary; AMR trades off; confab stills market
|
10/10/2012 | BKDDHY | S&P lowers Pharmaceutical Product, rates notes CCC+
|
10/10/2012 | BKDDHY | Moody's cuts Pharmaceutical, rates Holdco notes Caa1
|
10/10/2012 | HY | Jaguar Holding to sell $500 million five-year PIK toggle notes
|
12/5/2011 | BK | Market Commentary: Roundy's rises with IPO news; NPC shutting early; Alere reworks deal; High Liner sets talk
|
11/18/2011 | BK | Market Commentary: Pharmaceutical Product, Unifrax, B&G Foods, MoneyGram break; Alere add-on loan launches
|
11/17/2011 | HY | Market Commentary: No pricings, but market awaits Kodiak, Entercom; new deals in narrow range; Jefferies jarred
|
11/16/2011 | HY | Market Commentary: Drive-by Plains mega-deal, American Greetings, Atlas Pipeline price; ATP, MF Global gain
|
11/15/2011 | BKHY | Moody's: Pharmaceutical Product unchanged
|
11/15/2011 | BKHY | S&P: Pharmaceutical Product unchanged
|
11/15/2011 | HY | New Issue: Pharmaceutical Product Development sells $575 million 91/2% eight-year notes at par
|
11/15/2011 | HY | Market Commentary: Swift, upsized Pioneer Drilling, downsized Pharmaceutical Product price; ATP agony continues
|
11/15/2011 | BK | Pharmaceutical Product ups term loan B to $1.45 billion, trims spread
|
11/15/2011 | BK | Market Commentary: Nuveen dips with add-on news; Pharmaceutical Product reworks deal; FleetPride sets talk
|
11/14/2011 | BKHY | S&P rates Pharmaceutical Product loans BB-, notes B
|
11/14/2011 | BKHY | Moody's rates Pharmaceutical Product loans Ba3, notes B3
|
11/14/2011 | HY | Market Commentary: Community Health, Host Hotels price drive-bys; ATP Oil eroding; ResCap up ahead of coupon
|
11/9/2011 | HY | Pharmaceutical Product to sell $700 million eight-year notes
|
11/9/2011 | HY | Market Commentary: Petroleum Geo, Green Field price; market mostly off as stocks slide; ResCap, ATP big losers
|
11/8/2011 | BK | Market Commentary: Asset Acceptance frees up; Caesars rollercoasters with numbers; Dynegy rises on bankruptcy
|
11/4/2011 | BK | Market Commentary: Level 3 loans rise; Pharmaceutical Product sets launch, talk; Asset Acceptance tweaks deal
|
11/4/2011 | HY | Level 3 loans rise; Pharmaceutical Product sets launch, talk; Asset Acceptance tweaks
|
11/4/2011 | BK | Pharmaceutical Product sets Tuesday launch for $1.5 billion facility
|
11/1/2011 | BK | Pharmaceutical Product $1.5 billion loan launch likely Nov. 7 week
|
10/28/2011 | BK | Pharmaceutical Product $1.5 billion facility expected next month
|
10/24/2011 | HY | Market Commentary: Junk surges broadly, but mortgage-insurers fall; market awaits re-worked Chesapeake, Kinetic
|
10/14/2011 | BK | Pharmaceutical Product Development LBO financing to include $1.5 billion credit facility
|
10/14/2011 | HY | Pharmaceutical Product Development LBO to include $700 million notes
|
10/3/2011 | BK | Pharmaceutical Product plans $2.2 billion of debt for buyout
|
10/18/2006 | BT | Jefferies reiterates PPDI at buy
|
10/17/2006 | BT | Bear Stearns ups PPDI to outperform
|
10/17/2006 | BT | PPDI reiterated at buy by Jefferies
|
7/18/2006 | BT | PPD given buy rating by Jefferies
|
7/18/2006 | BT | Market Commentary: Tercica up 12%, Insmed rises 9%; Neurocrine closes weaker; Pharma Product up; New River deal emerges
|
6/29/2006 | BT | Jefferies recommends contract research sector after day 2 of Life Sciences Conference
|
4/19/2006 | BT | Jefferies gives PPDI buy rating
|
4/18/2006 | BT | Jefferies puts Pharmaceutical Product at buy
|
3/3/2006 | BT | Pharmaceutical Product Development obtains $80 million facility for new headquarters
|
2/10/2006 | BT | Jefferies: Pharmaceutical Product a buy
|
2/9/2006 | BT | Jefferies keeps Pharmaceutical Product at buy
|
12/9/2005 | BT | Jefferies reiterates PPDI at buy, $67 target
|
12/8/2005 | BT | Jefferies raises PPDI target to $67
|
10/27/2005 | BT | Jefferies keeps PPDI at buy
|
10/19/2005 | BT | Jefferies maintains PPDI at buy, raises price target
|
10/18/2005 | BT | Jefferies reiterates PPDI at buy
|
10/14/2005 | BT | Clinical trial demand makes early-stage biotech contract researchers look interesting, Jefferies says
|
10/12/2005 | BT | PPDI upgraded to buy by Jefferies
|
10/12/2005 | BT | Market Commentary: Vical falls 20% on PIPEs deal; Threshold, Dynavax off on stock sales; Pharma Product higher
|
7/14/2005 | BT | PPD price target upped by Jefferies
|